Friday, Aug. 21, 2015, 85 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $378.00 to $15,686,130.39.

Highlighted Stocks Traded by Insiders:

Edgewater Technology (EDGW) - FREE Research Report

Singleton Shirley, who is Chairman, President and CEO at Edgewater Technology, bought 2,200 shares at $7.15 on Aug. 21, 2015. Following this transaction, the Chairman, President and CEO owned 233,600 shares meaning that the stake was boosted by 0.95% with the 2,200-share transaction.

Clancey David, who is EVP & Chief Technology Officer at Edgewater Technology, bought 2,200 shares at $7.15 on Aug. 21, 2015. Following this transaction, the EVP & Chief Technology Officer owned 220,500 shares meaning that the stake was boosted by 1.01% with the 2,200-share transaction.

The shares most recently traded at $6.29, down $0.86, or 13.7% since the insider transaction.

The average volume for Edgewater Technology has been 15,400 shares per day over the past 30 days. Edgewater Technology has a market cap of $84.0 million and is part of the technology sector and computer software & services industry. Shares are down 4.86% year-to-date as of the close of trading on Friday.

Edgewater Technology, Inc., a strategic consulting company, provides classic consulting and product-based consulting services in North America. The company has a P/E ratio of 88.9. Currently, there are no analysts who rate Edgewater Technology a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EDGW - FREE

TheStreet Quant Ratings

rates Edgewater Technology as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Edgewater Technology Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Marathon Petroleum (MPC) - FREE Research Report

Griffith Timothy T., who is Sr. Vice President and CFO at Marathon Petroleum, bought 1,000 shares at $54.11 on Aug. 21, 2015. Following this transaction, the Sr. Vice President and CFO owned 23,892 shares meaning that the stake was boosted by 4.37% with the 1,000-share transaction.

The shares most recently traded at $46.81, down $7.30, or 15.59% since the insider transaction. Historical insider transactions for Marathon Petroleum go as follows:

  • 4-Week # shares bought: 2,775
  • 12-Week # shares bought: 2,775
  • 24-Week # shares bought: 2,775

The average volume for Marathon Petroleum has been 5.2 million shares per day over the past 30 days. Marathon Petroleum has a market cap of $29.2 billion and is part of the basic materials sector and energy industry. Shares are up 7.2% year-to-date as of the close of trading on Friday.

Marathon Petroleum Corporation, together with its subsidiaries, engages in refining, marketing, retailing, and transporting petroleum products primarily in the United States. It operates through three segments: Refining & Marketing, Speedway, and Pipeline Transportation. The stock currently has a dividend yield of 2.4%. The company has a P/E ratio of 9.3. Currently, there are 8 analysts who rate Marathon Petroleum a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPC - FREE

TheStreet Quant Ratings

rates Marathon Petroleum as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, notable return on equity, attractive valuation levels, good cash flow from operations and growth in earnings per share. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full

Marathon Petroleum Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Alimera (ALIM) - FREE Research Report

Green Kenneth, who is SVP & Chief Scientific Officer at Alimera, sold 20,000 shares at $3.29 on Aug. 21, 2015. Following this transaction, the SVP & Chief Scientific Officer owned 48,235 shares meaning that the stake was reduced by 29.31% with the 20,000-share transaction.

The shares most recently traded at $3.13, down $0.16, or 5.12% since the insider transaction. Historical insider transactions for Alimera go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 20,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 27,524
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 105,100

The average volume for Alimera has been 98,300 shares per day over the past 30 days. Alimera has a market cap of $157.7 million and is part of the health care sector and drugs industry. Shares are down 43.32% year-to-date as of the close of trading on Friday.

Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. The company focuses on diseases affecting the back of the eye or retina. Currently, there are 2 analysts who rate Alimera a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALIM - FREE

TheStreet Quant Ratings

rates Alimera as a

sell

. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and generally disappointing historical performance in the stock itself. Get the full

Alimera Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.